Cerebellar Atrophy with Phenytoin and Epilepsy
Cerebellar size measured by MRI was studied in a group of 36 adults (21 to 54 years, mean age 34 years) with intractable partial epilepsy treated with phenytoin longer than 4 years at the Epilepsy Center of the Long Island Jewish Medical Center, New Hyde Park, NY.
Main Author: | J Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
1994-09-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/2784 |
Similar Items
-
Relação dose-dependente do uso crônico de fenitoína e atrofia cerebelar em pacientes com epilepsia Dose-related cerebellar atrophy in patients with epilepsy using phenytoin
by: ANDRÉ DEL NEGRO, et al.
Published: (2000-06-01) -
CEREBELLAR ATROPHY WITH LONG-TERM PHENYTOIN (PHT) USE: CASE REPORT
by: Jamir P. Rissardo, et al.
Published: (2017-09-01) -
Rare case of phenytoin induced acute generalized exanthematous pustulosis with cerebellar syndrome
by: Pravin U Shingade, et al.
Published: (2014-01-01) -
Phenytoin toxicity secondary to friend's advice!!
by: Jisha Myalil Lucca, et al.
Published: (2019-01-01) -
Cerebellar atrophy in an epileptic child: is it due to phenytoin?
by: Ahuja S, et al.
Published: (2000-10-01)